Thr92Ala polymorphism of human type 2 deiodinase gene (hD2) affects the development of Graves' disease, treatment efficiency, and rate of remission

Clinical and Developmental Immunology

Volumn 2012, Issue , 2012, Pages

  Alina, Babenko ^a   Daria, Popkova ^a   Olga, Freylihman ^a   Vladislav, Solncev ^a   Anna, Kostareva ^a   Elena, Grineva ^a  

^a ALMAZOV NATIONAL MEDICAL RESEARCH CENTRE   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

IODIDE PEROXIDASE; LIOTHYRONINE; IODOTHYRONINE DEIODINASE TYPE II;

ADULT; ARTICLE; CODON; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME ACTIVITY; FEMALE; GENETIC ASSOCIATION; GENOTYPE; GRAVES DISEASE; HUMAN; LIOTHYRONINE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REMISSION; SINGLE NUCLEOTIDE POLYMORPHISM; THYROTOXICOSIS; TREATMENT RESPONSE; CASE CONTROL STUDY; ENZYMOLOGY; GENETICS; MIDDLE AGED;

ADULT; CASE-CONTROL STUDIES; FEMALE; GENOTYPE; GRAVES DISEASE; HUMANS; IODIDE PEROXIDASE; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; THYROTOXICOSIS;

EID: 84871366807     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2012/340542     Document Type: Article

References (17)

1. Schroner Z., Javorsky M., Kozarova M., Tkac I., Pharmacogenetics of oral antidiabetic treatment. Bratislavské Lekárske Listy 2011 112 8 441 446
2. Bianco A. C., Salvatore D., Gereben B., Berry M. J., Larsen P. R., Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocrine Reviews 2002 23 1 38 89 2-s2.0-0036191639 10.1210/er.23.1.38 (Pubitemid 34185306)
3. Köhrle J., Local activation and inactivation of thyroid hormones: the deiodinase family. Molecular and Cellular Endocrinology 1999 151 1-2 103 119 2-s2.0-0142214992 10.1016/S0303-7207(99)00040-4 (Pubitemid 29295518)
4. Salvatore D., Bartha T., Harney J. W., Larsen P. R., Molecular biological and biochemical characterization of the human type 2 selenodeiodinase. Endocrinology 1996 137 8 3308 3315 2-s2.0-0029938790 10.1210/en.137.8.3308 (Pubitemid 26250180)
5. Peeters R. P., Van Toor H., Klootwijk W., De Rijke Y. B., Kuiper G. G. J. M., Uitterlinden A. G., Visser T. J., Polymorphisms in thyroid hormone pathway genes are associated with plasma TSH and iodothyronine levels in healthy subjects. Journal of Clinical Endocrinology and Metabolism 2003 88 6 2880 2888 2-s2.0-0037563907 (Pubitemid 36724470)
6. Peeters R. P., van der Deure W. M., Visser T. J., Genetic variation in thyroid hormone pathway genes; polymorphisms in the TSH receptor and the iodothyronine deiodinases. European Journal of Endocrinology 2006 155 5 655 662 2-s2.0-33845270781 10.1530/eje.1.02279 (Pubitemid 44857488)
7. Maia A. L., Kim B. W., Huang S. A., Harney J. W., Larsen P. R., Type 2 iodothyronine deiodinase is the major source of plasma T3 in euthyroid humans. The Journal of Clinical Investigation 2005 115 9 2524 2533 2-s2.0-24644436920 10.1172/JCI25083 (Pubitemid 41266215)
8. Nicoloff J. T., Lum S. M., Spencer C. A., Morris R., Peripheral autoregulation of thyroxine to triiodothyronine conversion in man. Hormone and Metabolic Research, Supplement 1984 14 74 79 2-s2.0-0021727422
9. Pilo A., Iervasi G., Vitek F., Ferdeghini M., Cazzuola F., Bianchi R., Thyroidal and peripheral production of 3,5,3'-triiodothyronine in humans by multicompartmental analysis. American Journal of Physiology 1990 258 4 E715 E726 2-s2.0-0025366287 (Pubitemid 20142356)
10. Salvatore D., Tu H., Harney J. W., Larsen P. R., Type 2 iodothyronine deiodinase is highly expressed in human thyroid. The Journal of Clinical Investigation 1996 98 4 962 968 2-s2.0-0029832961 (Pubitemid 26293314)
11. Pachucki J., Hopkins J., Peeters R., Tu H., Carvalho S. D., Kaulbach H., Dale Abel E., Wondisford F. E., Ingwall J. S., Reed Larsen P., Type 2 iodothyronine deiodinase transgene expression in the mouse heart causes cardiac-specific thyrotoxicosis. Endocrinology 2001 142 1 13 20 2-s2.0-17744382979 10.1210/en.142.1.13 (Pubitemid 32183660)
12. Canani L. H., Capp C., Dora J. M., Souza Meyer E. L., Wagner M. S., Harney J. W., Larsen P. R., Gross J. L., Bianco A. C., Maia A. L., The type 2 deiodinase A/G (Thr92Ala) polymorphism is associated with decreased enzyme velocity and increased insulin resistance in patients with type 2 diabetes mellitus. Journal of Clinical Endocrinology and Metabolism 2005 90 6 3472 3478 2-s2.0-21244448050 10.1210/jc.2004-1977 (Pubitemid 41014316)
13. Guo T. W., Zhang F. C., Yang M. S., Gao X. C., Bian L., Duan S. W., Zheng Z. J., Gao J. J., Wang H., Li R. L., Feng G. Y., St Clair D., He L., Positive association of the DIO2 (deiodinase type 2) gene with mental retardation in the iodine-deficient areas of China. Journal of Medical Genetics 2004 41 8 585 590 2-s2.0-4043078477 (Pubitemid 39061263)
14. Mentuccia D., Proietti-Pannunzi L., Tanner K., Bacci V., Pollin T. I., Poehlman E. T., Shuldiner A. R., Celi F. S., Association between a novel variant of the human type 2 deiodinase gene Thr92Ala and insulin resistance: evidence of interaction with the Trp64Arg variant of the beta-3-adrenergic receptor. Diabetes 2002 51 3 880 883 2-s2.0-0036317754 (Pubitemid 34760206)
15. Gumieniak O., Perlstein T. S., Williams J. S., Hopkins P. N., Brown N. J., Raby B. A., Williams G. H., Ala92 type 2 deiodinase allele increases risk for the development of hypertension. Hypertension 2007 49 3 461 466 2-s2.0-33847082534 10.1161/01.HYP.0000256295.72185.fd
16. Grineva E., Babenko A., Vahrameeva N., Bogdanova M., Kostareva A., Popcova D., Larionova V., Type 2 deiodinase Thr92Ala polymorphism impact on clinical course and myocardial remodeling in patients with graves' disease. Cell Cycle 2009 8 16 2565 2569 2-s2.0-69249203789
17. Bahn R. S., Burch H. B., Cooper D. S., Hyperthyroidism management guidelines. Endocrine Practice 2011 17 3 1 65